Literature DB >> 85934

Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.

N R Peden, J H Saunders, K G Wormsley.   

Abstract

Ranitidine hydrochloride (an H2-receptor-blocking drug which does not contain the imidazole nucleus of histamine) powerfully inhibited nocturnal and pentagastrin-stimulated gastric secretion in fifteen patients with duodenal ulceration. The drug is satisfactorily absorbed and therefore warrants clinical trial.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 85934     DOI： 10.1016/s0140-6736(79)91146-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  35 in total

1.  Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.

Authors:  C W Howden; J A Forrest; J L Reid
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

2.  Lack of effect of ranitidine on warfarin action.

Authors:  M J Serlin; R G Sibeon; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

3.  Healing of gastric ulcers after one, two, and three months of ranitidine.

Authors:  M G Ashton; C D Holdsworth; F P Ryan; M Moore
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-13

4.  Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.

Authors:  R Mohammed; R J Holden; J B Hearns; B M McKibben; K D Buchanan; G P Crean
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

5.  Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships.

Authors:  M Mignon; N P Chau; B K Nguyen-Phuoc; M Sauvage; F Leguy; S Bonfils
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 6.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

7.  Effects of the H2 receptor antagonist ranitidine on anterior pituitary hormone secretion in man.

Authors:  G Delitala; L Devilla; A Pende; A Canessa
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.

Authors:  R P Walt; I F Trotman; R Frost; P L Golding; T H Shepherd; J Rawlings; R H Hunt; D Colin-Jones; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

9.  Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Br J Pharmacol       Date:  1981-01       Impact factor: 8.739

10.  Pharmacokinetics of the H2- receptor antagonist ranitidine in man.

Authors:  J J McNeil; G W Mihaly; A Anderson; A W Marshall; R A Smallwood; W J Louis
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.